CA
NZ
UK
AU
IND
US
…
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products under ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, Kimtech, KleenGuard, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, TouchNTuff, and VIKING brands. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ansell Ltd ADR makes protective solutions such as medical and industrial gloves and safety products sold to healthcare, industrial and other commercial customers worldwide. Long-term growth drivers include persistent demand for personal protective equipment, tighter workplace safety regulation, product innovation and expansion into emerging markets, which could support revenue and margin resilience.
Key risks include intense competition and pricing pressure, raw-material and manufacturing-cost volatility, regulatory and supply-chain disruptions, and potential demand normalization after pandemic-driven spikes.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | 143.90M | 108.70M | 189.60M | 208.40M | 318.10M |
| Minority interest | -2.00M | -1.00M | -1.60M | -1.10M | 13.40M |
| Net income | 101.60M | 76.50M | 148.30M | 158.70M | 246.70M |
| Selling general administrative | 641.10M | 321.30M | 406.20M | 429.20M | 480.10M |
| Selling and marketing expenses | 641.10M | 108.00M | 406.20M | 429.20M | 480.10M |
| Gross profit | 825.00M | 624.80M | 616.70M | 665.80M | 810.00M |
| Reconciled depreciation | 74.80M | 72.60M | 68.00M | 65.30M | 64.10M |
| Ebit | 185.40M | 129.70M | 207.20M | 226.60M | 353.46M |
| Ebitda | 260.20M | 202.30M | 275.20M | 291.90M | 401.60M |
| Depreciation and amortization | 74.80M | 72.60M | 68.00M | 65.30M | 48.14M |
| Operating income | 109.10M | 56.70M | 316.04M | 367.31M | 439.95M |
| Other operating expenses | 1894.20M | 1490.00M | 942.13M | 1223.75M | 989.26M |
| Interest expense | 46.22M | 25.00M | 17.60M | 18.20M | 19.40M |
| Tax provision | 40.30M | 31.20M | 39.70M | 48.60M | 69.80M |
| Interest income | 6.30M | 4.40M | - | - | 1.20M |
| Net interest income | -40.00M | -20.60M | -19.40M | -19.70M | -18.20M |
| Income tax expense | 40.30M | 31.20M | 39.70M | 48.60M | 69.80M |
| Total revenue | 2003.30M | 1619.30M | 1655.10M | 1952.10M | 2026.90M |
| Total operating expenses | 715.90M | 495.50M | 474.20M | 494.50M | 544.20M |
| Cost of revenue | 1178.30M | 994.50M | 1038.40M | 1286.30M | 1216.90M |
| Total other income expense net | 34.80M | -20.60M | -1.50M | -8.50M | 8.10M |
| Net income from continuing ops | 103.60M | 77.50M | 149.90M | 159.80M | 248.30M |
| Net income applicable to common shares | - | - | 148.30M | 158.70M | 246.70M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 3322.40M | 3242.60M | 2530.60M | 2506.20M | 2737.70M |
| Intangible assets | 320.20M | 212.50M | 214.40M | 1049.40M | 225.70M |
| Other current assets | 41.30M | 41.80M | 31.10M | 38.10M | 37.40M |
| Total liab | 1339.70M | 1332.40M | 915.20M | 949.60M | 1173.10M |
| Total stockholder equity | 1963.60M | 1894.90M | 1600.90M | 1542.90M | 1551.20M |
| Other current liab | 190.10M | 111.00M | 367.69M | 185.83M | 256.72M |
| Common stock | 1027.00M | 1028.20M | 750.70M | 743.80M | 769.00M |
| Capital stock | 1027.00M | 1028.20M | 750.70M | 743.80M | 769.00M |
| Retained earnings | 1097.20M | 1059.80M | 1026.60M | 942.00M | 866.80M |
| Other liab | - | - | 123.60M | 121.70M | 128.50M |
| Good will | 1335.30M | 842.30M | 845.30M | 834.40M | 851.40M |
| Other assets | - | 0.00M | 122.10M | 95.80M | 114.70M |
| Cash | 238.30M | 912.30M | 159.40M | 206.20M | 240.20M |
| Total current liabilities | 522.00M | 423.40M | 414.60M | 360.30M | 549.90M |
| Current deferred revenue | - | 9.40M | -289.89M | -120.03M | -85.02M |
| Net debt | 567.30M | -55.10M | 334.90M | 279.60M | 275.30M |
| Short term debt | 81.00M | 77.50M | 117.30M | 18.20M | 20.80M |
| Short long term debt | 60.40M | 59.70M | 100.00M | - | - |
| Short long term debt total | 805.60M | 857.20M | 494.30M | 485.80M | 515.50M |
| Other stockholder equity | - | -16.10M | -2668.44M | -2441.71M | -2181.50M |
| Property plant equipment | - | - | 436.80M | 356.60M | 356.00M |
| Total current assets | 1110.80M | 1623.90M | 912.00M | 984.50M | 1166.90M |
| Long term investments | 1.10M | 5.60M | 6.50M | 18.00M | 21.90M |
| Net tangible assets | - | - | 541.20M | 493.50M | 474.10M |
| Short term investments | - | - | 11.82M | 10.82M | 8.77M |
| Net receivables | 246.50M | 211.90M | 191.20M | 201.70M | 274.20M |
| Long term debt | 638.50M | 706.60M | 307.00M | 426.30M | 451.70M |
| Inventory | 584.70M | 457.90M | 526.10M | 521.30M | 611.20M |
| Accounts payable | 250.90M | 225.50M | 219.50M | 276.30M | 357.40M |
| Accumulated other comprehensive income | -160.60M | -193.10M | -176.40M | -142.90M | -84.60M |
| Non currrent assets other | 40.50M | 35.40M | 42.00M | 32.60M | 32.70M |
| Non current assets total | 2211.60M | 1618.70M | 1618.60M | 1521.70M | 1570.80M |
| Capital lease obligations | 106.70M | 90.90M | 87.30M | 59.50M | 63.80M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Investments | -703.30M | -63.40M | -75.50M | -5.10M | -1.70M |
| Change to liabilities | - | - | -78.90M | -94.70M | 124.20M |
| Total cashflows from investing activities | -703.30M | -63.40M | -75.50M | -71.20M | -84.70M |
| Net borrowings | -82.00M | 360.70M | -59.50M | -17.10M | -112.10M |
| Total cash from financing activities | -216.00M | 540.80M | -149.20M | -176.70M | -267.50M |
| Change to operating activities | - | - | 0.70M | -48.90M | 16.10M |
| Net income | 101.60M | 76.50M | 222.66M | 229.86M | 329.00M |
| Change in cash | -674.00M | 752.90M | -46.80M | -34.00M | -168.70M |
| Begin period cash flow | 912.30M | 159.40M | 206.20M | 240.20M | 408.90M |
| End period cash flow | 238.30M | 912.30M | 159.40M | 206.20M | 240.20M |
| Total cash from operating activities | 239.30M | 254.50M | 271.00M | 321.54M | 230.45M |
| Issuance of capital stock | - | 305.20M | 0.30M | 103.20M | - |
| Depreciation | - | 72.60M | 96.99M | 87.19M | 76.55M |
| Other cashflows from investing activities | 1.30M | -0.60M | 2.70M | 2.70M | 2.70M |
| Dividends paid | 63.70M | 53.20M | -62.90M | -86.80M | -77.30M |
| Change to inventory | -93.54M | 61.40M | 13.21M | 98.35M | -347.40M |
| Change to account receivables | -20.86M | -23.00M | 22.22M | 85.60M | -107.89M |
| Sale purchase of stock | -4.40M | -30.00M | -8.00M | -48.50M | -58.00M |
| Other cashflows from financing activities | -65.90M | -41.90M | -19.20M | -45.80M | -20.80M |
| Change to netincome | - | - | 15.10M | 32.90M | 46.70M |
| Capital expenditures | 69.30M | 62.80M | 67.30M | 72.60M | 82.70M |
| Change in working capital | -47.52M | 37.60M | 35.43M | 183.95M | -455.29M |
| Stock based compensation | - | 6.20M | -8.26M | -3.77M | 40.14M |
| Other non cash items | 286.82M | 67.80M | -48.65M | 4.49M | -175.10M |
| Free cash flow | 170.00M | 191.70M | 203.70M | 248.94M | 147.75M |
Sector: Healthcare Industry: Medical Instruments & Supplies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ANSLY Ansell Ltd ADR |
- -% |
124.00 | 22.45 | 17.76 | 1.48 | 1.51 | 1.68 | 11.15 |
| ISRG Intuitive Surgical Inc |
-16.75 3.73% |
432.01 | 43.30 | 31.35 | 12.25 | 7.35 | 11.63 | 30.22 |
| ESLOF EssilorLuxottica Société anonyme |
1.51 0.74% |
205.00 | 44.84 | 27.62 | 4.07 | 2.49 | 3.71 | 16.04 |
| ESLOY Essilor International SA |
2.86 2.87% |
102.66 | 41.68 | 27.25 | 3.94 | 2.45 | 3.71 | 16.04 |
| BDX Becton Dickinson and Company |
-0.46 0.23% |
197.88 | 31.62 | 13.76 | 2.25 | 2.04 | 2.93 | 13.40 |
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products under ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, Kimtech, KleenGuard, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, TouchNTuff, and VIKING brands. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Neil I. Salmon ACMA, BA | MD, CEO & Director | 1969 |
| Mr. Zubair Javeed | Chief Financial Officer | NA |
| Mr. Darryl Nazareth | Pres of Healthcare GBU | NA |
| Mr. Rikard Fröberg MA, MS | Pres of the Industrial Global Bus. Unit (IGBU) | NA |
| Mr. John Marsden | Sr. VP of Global Operations & Global Supply Chain | NA |
| Ms. Deanna Johnston | Sr. VP & Global Chief Information Officer | NA |
| Michael Evans | Director of Corp. Devel. & Investor Relation | NA |
| Mr. Michael Gilleece | Sr. VP & Corp. Gen. Counsel | NA |
| Ms. Amanda Manzoni | Chief HR Officer | NA |
| Mr. Francois Le Jeune BS, MBA, MS | Chief Commercial Officer of EMEA, APAC & Guardian Admin. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...